Ping Shen

Ping Shen

Auto-generated profile, based on publicly available information

Ping Shen

Pitzer Laboratory of Osteoarthritis Research, German Rheumatism Research Center (DRFZ), A Leibniz Institute, Berlin, Germany

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PSPing Shen
Ping Shen
SSSebastian Serve
Sebastian Serve
PWPeihua Wu
Peihua Wu
XLXiaohui Liu
Xiaohui Liu
YDYujie Dai
Yujie Dai
MLMax Löhning
Max Löhning
Osteoarthritis (OA) is a joint disease featuring cartilage breakdown and chronic pain. Although age and joint trauma are prominently associated with OA occurrence, the trigger and signaling pathways propagating their pathogenic aspects are ill defined. Following long-term catabolic activity and traumatic cartilage breakdown, debris accumulates and can trigger Toll-like receptors (TLRs). Here we show that TLR2 stimulation suppressed the expression of matrix proteins and induced an inflammatory phenotype in human chondrocytes. Further, TLR2 stimulation impaired chondrocyte mitochondrial function, resulting in severely reduced adenosine triphosphate (ATP) production. RNA-sequencing analysis revealed that TLR2 stimulation upregulated nitric oxide synthase 2 ( NOS2 ) expression and downregulated mitochondria function-associated genes. NOS inhibition partially restored the expression of these genes, and rescued mitochondrial function and ATP production. Correspondingly, Nos2 −/− mice were protected from age-related OA development. Taken together, the TLR2–NOS axis promotes human chondrocyte dysfunction and murine OA development, and targeted interventions may provide therapeutic and preventive approaches in OA.

11 April 2022 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
YLYonghai Li
Yonghai Li
HGHaiyao Gao
Haiyao Gao
TBTobias M. Brunner
Tobias M. Brunner
XHXiaoxi Hu
Xiaoxi Hu
YYYushan Yan
Yushan Yan
PSPing Shen
Ping Shen
Background: Immunosuppressive properties grant mesenchymal stromal cells (MSCs) promising potential for treating autoimmune diseases. As autologous MSCs suffer from limited availability, the readily available allogeneic MSCs isolated from menstrual blood (MB-MSCs) donated by young, healthy individuals offer great potential. Here, we evaluate the therapeutic potential of MB-MSCs as ready-to-use allo-MSCs in multiple sclerosis, an autoimmune disease developed by the activation of myelin sheath-reactive Th1 and Th17 cells, by application in its animal model experimental autoimmune encephalomyelitis (EAE). Methods: We assessed the therapeutic effect of MB-MSCs transplanted via either intravenous (i.v.) or intraperitoneal (i.p.) route in EAE in comparison with umbilical cord-derived MSCs (UC-MSCs). We used histology to assess myelin sheath integrity and infiltrated immune cells in CNS and flow cytometry to evaluate EAE-associated inflammatory T cells and antigen-presenting cells in lymphoid organs. Results: We observed disease-ameliorating effects of MB-MSCs when transplanted at various stages of EAE (day − 1, 6, 10, and 19), via either i.v. or i.p. route, with a potency comparable to UC-MSCs. We observed reduced Th1 and Th17 cell responses in mice that had received MB-MSCs via either i.v. or i.p. injection. The repressed Th1 and Th17 cell responses were associated with a reduced frequency of plasmacytoid dendritic cells (pDCs) and a suppressed co-stimulatory capacity of pDCs, cDCs, and B cells. Conclusions: Our data demonstrate that the readily available MB-MSCs significantly reduced the disease severity of EAE upon transplantation. Thus, they have the potential to be developed as ready-to-use allo-MSCs in MS-related inflammation. Graphical


1 January 2002 in Journal of Asian Natural Products Research
Verified
Journal Article
Closed access
PSPing Shen
Ping Shen
SWSan-Long Wang
San-Long Wang
XLXi-Kui Liu
Xi-Kui Liu
CYChong-Ren Yang
Chong-Ren Yang
BCBing Cai
Bing Cai
XYXin-sheng Yao
Xin-sheng Yao
From the fresh rhizomes of Dioscorea deltoidea Wall var. orbiculata , a novel ergostanol saponin, orbiculatoside A ( 1 ), was isolated and identified as 3- O - g - d -glucopyranosyl-ergost-5-ene-3 g , 26-diol-26- O - g - d -glucopyranosyl(1 M 3)-[ g - d -glucopyranosyl(1 M 2)- g - d -glucupyranosyl(1 M 6)]- g - d -glucopyranoside by various NMR techniques in combination with chemical methods. The new saponin showed strong activity against Pyricularia oryzae , with a MMDC (minimum morphological deformation concentration) value of 28.04 w mol/l and was cytotoxic to cancer cell line K562, HCT-15, A549, HT1080, and A2780a in vitro .

21 November 2022 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PSPing Shen
Ping Shen
PWPeihua Wu
Peihua Wu
TMTazio Maleitzke
Tazio Maleitzke
MRMarie-Jacqueline Reisener
Marie-Jacqueline Reisener
GHGitta A. Heinz
Gitta A. Heinz
MLMax Löhning
Max Löhning
The isolation of chondrocytes from human articular cartilage for single-cell RNA sequencing requires extensive and prolonged tissue digestion at 37 C. Modulations of the transcriptional activity likely take place during this period such that the transcriptomes of isolated human chondrocytes no longer match their original status in vivo. Here, we optimized the human chondrocyte isolation procedure to maximally preserve the in vivo transcriptome. Cartilage tissues were transferred into a hypoxia chamber (4% O2) immediately after being removed from OA patients and minced finely. Collagenase II at concentrations of 0.02%, 0.1%, 0.25%, 0.5%, 1%, and 2% was applied for 0.5, 1, 2, 4, and 18 h to digest the minced tissue. Actinomycin D (ActD) was added to test its capacity in stabilizing the transcriptome. Cell yield, viability, cell size, and transcriptome were determined using counter chamber, flow cytometry, and RNA sequencing (RNA-seq). Collagenase II at 2% concentration released small chondrocytes from cartilage matrix during the first digestion hour and started to release large cells thereafter, reaching a complete release at 4 h. During 4-h digestions, collagenase II at 2% and 1% but not at lower concentrations yielded maximal release also of the large chondrocyte population. RNA-seq analysis revealed that a 4-h digestion period with 1% or 2% collagenase II plus Actinomycin D optimally preserved the transcriptome. Thus, this study provides an isolation protocol for single chondrocytes from human articular cartilage optimized for transcriptome preservation and RNA-seq analysis.

12 April 2022 in Zeitschrift für Rheumatologie
Verified
Journal Article
Closed access
PDF file
MLMax Löhning
Max Löhning
PSPing Shen
Ping Shen
MDMaria Dzamukova
Maria Dzamukova
NDNayar Durán-Hernández
Nayar Durán-Hernández
JRJay Roodselaar
Jay Roodselaar
FBFrank Buttgereit
Frank Buttgereit